<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
                    <title>Endocrinology</title>
            <link>https://medicalxpress.com/endocrinology-metabolism-news/</link>
            <language>en-us</language> 
            <description>Latest medical news and research in Endocrinology</description>

                            <item>
                    <title>New state-by-state scorecard reveals wide gaps in access to obesity treatments</title>
                    <description>Where Americans live can make a profound difference in their ability to access obesity treatment, according to a new state-by-state scorecard and report that gives 20 states D or F grades and finds significant barriers to care in every state in the nation.</description>
                    <link>https://medicalxpress.com/news/2026-11-state-scorecard-reveals-wide-gaps.html</link>
                    <category></category>
                    <pubDate>Thu, 19 Nov 2026 21:00:02 EST</pubDate>
                    <guid isPermaLink="false">news714316405</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/weight-loss-clinic.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>International report discusses risks of chemicals in everyday items</title>
                    <description>Two University of Massachusetts Amherst researchers made significant contributions to a new report—more than 10 years in the making—from the United Nations Environment Program (UNEP) and the World Health Organization (WHO) that finds hormone-disrupting chemicals are a &quot;global and growing threat&quot; to human health and the environment.</description>
                    <link>https://medicalxpress.com/news/2026-11-international-discusses-chemicals-everyday-items.html</link>
                    <category></category>
                    <pubDate>Thu, 19 Nov 2026 20:00:05 EST</pubDate>
                    <guid isPermaLink="false">news714316164</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/cleaning-product.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Anti-inflammatory peptide shows potential to prevent diabetes-related vision loss</title>
                    <description>According to a study published in October in the journal Biomedicine &amp; Pharmacotherapy, a molecule naturally produced by the human body may help protect vision against damage caused by high blood sugar. This finding paves the way for new strategies to prevent diabetic retinopathy. This complication affects more than 22% of people with diabetes worldwide. It occurs when high blood sugar levels cause inflammation and damage neurons and blood vessels in the retina, which can lead to permanent vision loss.</description>
                    <link>https://medicalxpress.com/news/2026-11-anti-inflammatory-peptide-potential-diabetes.html</link>
                    <category></category>
                    <pubDate>Thu, 19 Nov 2026 19:40:22 EST</pubDate>
                    <guid isPermaLink="false">news714330061</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/study-identifies-molec.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Common type 1 diabetes score misses over half of partial remissions in youth with overweight or obesity</title>
                    <description>A Baylor College of Medicine–led team is raising awareness about applying the widely used values of insulin dose-adjusted hemoglobin A1c (IDAA1c) when screening for partial type 1 diabetes remission in youth with overweight or obesity. The study appeared in Diabetes Care.</description>
                    <link>https://medicalxpress.com/news/2026-11-common-diabetes-score-partial-remissions.html</link>
                    <category></category>
                    <pubDate>Thu, 19 Nov 2026 17:50:04 EST</pubDate>
                    <guid isPermaLink="false">news714329521</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2020/6-diabetes.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Discovery points to new approach for treating diabetes—no insulin required</title>
                    <description>Researchers at the University of Cincinnati College of Medicine have identified a previously unknown way the body&#039;s muscles absorb glucose from the blood—without insulin.</description>
                    <link>https://medicalxpress.com/news/2026-11-discovery-approach-diabetes-insulin-required.html</link>
                    <category></category>
                    <pubDate>Thu, 19 Nov 2026 16:20:02 EST</pubDate>
                    <guid isPermaLink="false">news714323521</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/discovery-points-to-ne.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Type 1 and type 2 diabetes therapies show great promise—but treatment is only effective if people can access it</title>
                    <description>In 2026, over 830 million people worldwide are estimated to live with diabetes—more than ever before.</description>
                    <link>https://medicalxpress.com/news/2026-11-diabetes-therapies-great-treatment-effective.html</link>
                    <category></category>
                    <pubDate>Thu, 19 Nov 2026 15:00:07 EST</pubDate>
                    <guid isPermaLink="false">news714306377</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/finger-prick-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Smart floss can measure blood sugar and inflammation markers</title>
                    <description>While the biological link between oral health and whole-body wellness has long been recognized, medicine has lacked practical tools to monitor both at home. To bridge this gap, an interdisciplinary research team led by The Hong Kong University of Science and Technology (HKUST) has developed an innovative gingival fluid device (GFD) featuring a disposable &quot;Smart Floss&quot; with a microfluidic channel and sensor array built directly inside.</description>
                    <link>https://medicalxpress.com/news/2026-11-smart-floss-blood-sugar-inflammation.html</link>
                    <category></category>
                    <pubDate>Thu, 19 Nov 2026 12:40:15 EST</pubDate>
                    <guid isPermaLink="false">news714306901</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/team-creates-smart-flo-2.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Traffic noise linked to increased risk of type 2 diabetes</title>
                    <description>Long-term exposure to noise from road traffic and trains is linked to an increased risk of type 2 diabetes, even at relatively low noise levels. This is shown in a large Scandinavian study involving researchers at the Institute of Environmental Medicine (IMM) at Karolinska Institutet, published in the journal Environmental Health Perspectives.</description>
                    <link>https://medicalxpress.com/news/2026-11-traffic-noise-linked-diabetes.html</link>
                    <category></category>
                    <pubDate>Thu, 19 Nov 2026 11:20:03 EST</pubDate>
                    <guid isPermaLink="false">news714293602</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/traffic-noise-linked-t.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>The connection between high-fat ketogenic diets and weight loss</title>
                    <description>Ketogenic diets have attracted enormous attention for their purported health benefits, particularly their ability to promote weight loss. Despite their popularity, studies investigating the composition of these high-fat, low-carbohydrate regimens have produced inconsistent results. Some studies have found substantial metabolic benefits, while others have found little or no improvement.</description>
                    <link>https://medicalxpress.com/news/2026-11-high-fat-ketogenic-diets-weight.html</link>
                    <category></category>
                    <pubDate>Thu, 19 Nov 2026 10:20:10 EST</pubDate>
                    <guid isPermaLink="false">news714304922</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/keto-diet-3.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Study identifies key immune mechanism in the brain involved in metabolic control</title>
                    <description>An international study has found new evidence of a key element in how our body and brain communicate, opening the door to new research on obesity and related metabolic disorders. This work was authored by Dr. Sonia Fernández-Veledo and Maria Repollés-de-Dalmau at the Southern Catalonia Biomedical Research Institute (IRB CatSud) in collaboration with the University of Cambridge and other partners.</description>
                    <link>https://medicalxpress.com/news/2026-11-key-immune-mechanism-brain-involved.html</link>
                    <category></category>
                    <pubDate>Thu, 19 Nov 2026 09:20:13 EST</pubDate>
                    <guid isPermaLink="false">news714291979</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/study-identifies-key-i.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Sugar made by gut bacterium may help the body burn visceral fat</title>
                    <description>Scientists have discovered that a sugar produced by a gut bacterium can increase energy burning in visceral fat—the harmful fat that accumulates around internal organs—while reducing weight gain and improving metabolic health, offering a potential new approach to tackling obesity.</description>
                    <link>https://medicalxpress.com/news/2026-11-sugar-gut-bacterium-body-visceral.html</link>
                    <category></category>
                    <pubDate>Thu, 19 Nov 2026 06:40:08 EST</pubDate>
                    <guid isPermaLink="false">news714291914</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/sugar-made-by-gut-bact.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Acupuncture‑like treatment linked to sustained weight loss in new study</title>
                    <description>A form of acupuncture that leaves dissolvable threads under the skin may help people lose weight, a small trial in China suggests.</description>
                    <link>https://medicalxpress.com/news/2026-11-acupuncturelike-treatment-linked-sustained-weight.html</link>
                    <category></category>
                    <pubDate>Wed, 18 Nov 2026 16:40:07 EST</pubDate>
                    <guid isPermaLink="false">news714223472</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/acupuncture-2.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>1 in 10 U.S. adults reported GLP-1 medication use July to August 2025</title>
                    <description>From July to August 2025, about one in 10 U.S. adults reported taking a glucagon-like peptide-1 receptor agonist (GLP-1 RA) medication during the past year, according to research published in Morbidity and Mortality Weekly Report.</description>
                    <link>https://medicalxpress.com/news/2026-11-adults-glp-medication-july-august.html</link>
                    <category></category>
                    <pubDate>Wed, 18 Nov 2026 12:00:10 EST</pubDate>
                    <guid isPermaLink="false">news714218769</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/glp-1-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New guidance addresses GLP-1 medication use and eating disorders</title>
                    <description>GLP-1 medications are widely used to treat type 2 diabetes and help some people manage their weight. These medications can reduce appetite and help people feel full sooner. Early research also suggests they may help reduce binge-eating episodes for some people.</description>
                    <link>https://medicalxpress.com/news/2026-11-guidance-glp-medication-disorders.html</link>
                    <category></category>
                    <pubDate>Wed, 18 Nov 2026 11:20:01 EST</pubDate>
                    <guid isPermaLink="false">news714218175</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/ozempic-4.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Semaglutide may improve eating disorder symptoms and body image in adults seeking obesity treatment</title>
                    <description>Adults receiving semaglutide for obesity treatment experienced greater improvements in several measures of disordered eating, eating disorder symptoms and body image concerns compared with participants receiving placebo, according to a new study led by researchers from the Perelman School of Medicine at the University of Pennsylvania. The study was published in the International Journal of Eating Disorders.</description>
                    <link>https://medicalxpress.com/news/2026-11-semaglutide-disorder-symptoms-body-image.html</link>
                    <category></category>
                    <pubDate>Wed, 18 Nov 2026 07:00:01 EST</pubDate>
                    <guid isPermaLink="false">news714204360</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/semaglutide-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Multiple short walks better than one long walk for controlling blood sugar</title>
                    <description>A randomized trial published in Obesity indicates that interrupting prolonged sitting with frequent brisk walks can improve blood glucose regulation to a greater extent than the same amount of walking performed as a single continuous bout.</description>
                    <link>https://medicalxpress.com/news/2026-11-multiple-short-blood-sugar.html</link>
                    <category></category>
                    <pubDate>Wed, 18 Nov 2026 03:10:02 EST</pubDate>
                    <guid isPermaLink="false">news714056263</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/walking-3.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>GLP-1 weight-loss drugs linked to inadequate intake of key nutrients in some people</title>
                    <description>Drugs taken to suppress appetite, such as Wegovy and Mounjaro, are associated with inadequate intakes of key nutrients and energy in some people, finds a small exploratory study published in the journal BMJ Nutrition Prevention &amp; Health.</description>
                    <link>https://medicalxpress.com/news/2026-11-glp-weight-loss-drugs-linked.html</link>
                    <category></category>
                    <pubDate>Tue, 17 Nov 2026 18:30:06 EST</pubDate>
                    <guid isPermaLink="false">news714054841</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/person-taking-suppleme.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Why don&#039;t GLP‑1 obesity drugs work for everyone?</title>
                    <description>Medications like Ozempic and Wegovy, which contain semaglutide—a GLP‑1 receptor agonist that helps regulate blood sugar, appetite and body weight—have become household names and important pillars in obesity management for the medical profession.</description>
                    <link>https://medicalxpress.com/news/2026-11-dont-glp1-obesity-drugs.html</link>
                    <category></category>
                    <pubDate>Tue, 17 Nov 2026 15:00:15 EST</pubDate>
                    <guid isPermaLink="false">news714132445</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/semaglutide-3.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Five things that shape body weight—by an obesity expert</title>
                    <description>What you eat when you&#039;re tired and hungry might come down to what&#039;s open on the way home and what you can afford. Both appetite and access to food shape decisions that can look, from the outside, like simple matters of choice.</description>
                    <link>https://medicalxpress.com/news/2026-11-body-weight-obesity-expert.html</link>
                    <category></category>
                    <pubDate>Tue, 17 Nov 2026 14:30:01 EST</pubDate>
                    <guid isPermaLink="false">news714132274</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/snacking.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New tool enables early intervention for diabetic foot ulcers</title>
                    <description>Australian researchers and clinicians have developed an AI-powered thermal imaging tool to predict if diabetes-related foot ulcers are likely to heal, potentially reducing hospitalizations and amputations.</description>
                    <link>https://medicalxpress.com/news/2026-11-tool-enables-early-intervention-diabetic.html</link>
                    <category></category>
                    <pubDate>Tue, 17 Nov 2026 12:00:03 EST</pubDate>
                    <guid isPermaLink="false">news714128131</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/new-tool-enables-early-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>People with diabetes demand greater control over health data in new digital rights charter</title>
                    <description>A new international Diabetes Data Rights Charter is calling for people with diabetes to have far greater control over the health data generated by 24/7 diabetes monitoring devices.</description>
                    <link>https://medicalxpress.com/news/2026-11-people-diabetes-demand-greater-health.html</link>
                    <category></category>
                    <pubDate>Tue, 17 Nov 2026 08:50:02 EST</pubDate>
                    <guid isPermaLink="false">news714118716</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/continuous-glucose-mon.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Q&amp;A: Can the body&#039;s natural signals help wounds heal better with diabetes?</title>
                    <description>Type 1 diabetes, an autoimmune condition in which the pancreas doesn&#039;t produce enough insulin, can make it harder for wounds to heal. Researchers are exploring why and how the body&#039;s natural healing processes could be improved. Pedro Geralde, PD, a professor at the Université de Sherbrooke in Canada, shared his team&#039;s work at the American Physiological Society&#039;s 2026 Comparative Physiology conference last month. We caught up with Geralde to learn more.</description>
                    <link>https://medicalxpress.com/news/2026-11-qa-body-natural-wounds-diabetes.html</link>
                    <category></category>
                    <pubDate>Mon, 16 Nov 2026 12:50:01 EST</pubDate>
                    <guid isPermaLink="false">news714051585</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2023/wound.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Ending Medicaid coverage for weight-loss drugs linked to sharp drop in GLP-1 use</title>
                    <description>Medicaid prescriptions for weight loss–approved GLP-1 medications fell sharply after four states ended coverage of the drugs, according to a new study led by researchers at the University of Pittsburgh. The findings, published in JAMA, demonstrate how state coverage decisions can have an immediate and substantial effect on access to these medications.</description>
                    <link>https://medicalxpress.com/news/2026-11-medicaid-coverage-weight-loss-drugs.html</link>
                    <category></category>
                    <pubDate>Mon, 16 Nov 2026 11:00:09 EST</pubDate>
                    <guid isPermaLink="false">news714033754</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/glp-1-medications.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Weekly weight-loss injection combo shows promise</title>
                    <description>Two lower doses of CagriSema, a weekly injection combining two appetite-reducing medicines, cagrilintide and semaglutide, led to substantial weight loss in adults with obesity or with overweight and a weight-related health condition such as high blood pressure or sleep apnea, according to the REDEFINE 9 randomized controlled trial published in The Lancet Diabetes &amp; Endocrinology journal.</description>
                    <link>https://medicalxpress.com/news/2026-11-weekly-weight-loss-combo.html</link>
                    <category></category>
                    <pubDate>Mon, 16 Nov 2026 07:40:04 EST</pubDate>
                    <guid isPermaLink="false">news714032060</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/weekly-weight-loss-inj.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Researchers trial AI coach for diabetes</title>
                    <description>For many people with type 2 diabetes, the challenge isn&#039;t understanding what they need to do to stay well. It&#039;s doing it consistently. Managing the condition often requires a long-term commitment to healthier eating patterns, regular exercise and medication. But unlike some illnesses, diabetes can progress quietly. Missing a dose or skipping exercise may not cause immediate consequences, making it easy for healthy intentions to slip amid the demands of work, family and everyday life.</description>
                    <link>https://medicalxpress.com/news/2026-11-trial-ai-diabetes.html</link>
                    <category></category>
                    <pubDate>Fri, 13 Nov 2026 22:20:01 EST</pubDate>
                    <guid isPermaLink="false">news713797361</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/researchers-trial-ai-c.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>GLP-1s often contain untested additive combinations, study finds</title>
                    <description>Use of GLP-1 receptor agonist medications (GLP-1s) has skyrocketed in recent years, and many people are using &quot;compounded&quot; GLP-1 products: medicines that include GLP-1s as well as other active substances, some of which are not regulated by the FDA. A new study found that compounded GLP-1s now make up a large majority of weight-loss medicines, commonly containing vitamin B12 analogs that have not been tested for safety in combination with GLP-1s.</description>
                    <link>https://medicalxpress.com/news/2026-11-glp-1s-untested-additive-combinations.html</link>
                    <category></category>
                    <pubDate>Fri, 13 Nov 2026 16:00:01 EST</pubDate>
                    <guid isPermaLink="false">news713800264</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/glp-1-medications.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Vitamin D may help control lung inflammation during flu infection, study in mice suggests</title>
                    <description>Vitamin D may help the body fight influenza by controlling inflammation and the amount of virus in the lungs, according to a study in mice led by researchers at Penn State.</description>
                    <link>https://medicalxpress.com/news/2026-11-vitamin-d-lung-inflammation-flu.html</link>
                    <category></category>
                    <pubDate>Fri, 13 Nov 2026 10:40:01 EST</pubDate>
                    <guid isPermaLink="false">news713774598</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/vitamin-d-may-help-con-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>China approves first oral GLP-1 weight-loss pill</title>
                    <description>China has approved its first orally administered GLP-1 weight-loss drug, permitting Eli Lilly to sell its orforglipron pill in a market where 630 million adults could be overweight or obese by 2050.</description>
                    <link>https://medicalxpress.com/news/2026-11-china-oral-glp-weight-loss.html</link>
                    <category></category>
                    <pubDate>Fri, 13 Nov 2026 05:20:01 EST</pubDate>
                    <guid isPermaLink="false">news713768997</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/weight-loss-drugs.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Pilot study tests cell therapy for difficult-to-heal diabetic foot ulcers</title>
                    <description>An experimental cell therapy was well tolerated in 10 people with chronic diabetic foot ulcers, according to a first-in-human study led by researchers at Wake Forest Institute for Regenerative Medicine (WFIRM).</description>
                    <link>https://medicalxpress.com/news/2026-11-cell-therapy-difficult-diabetic-foot.html</link>
                    <category></category>
                    <pubDate>Thu, 12 Nov 2026 17:00:02 EST</pubDate>
                    <guid isPermaLink="false">news713716021</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/pilot-study-tests-cell.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Mediterranean diet can help clear fat from the pancreas and improve blood-sugar control</title>
                    <description>Fat that builds up in the pancreas is one of the lesser-known risk factors for diabetes and metabolic syndrome, but it turns out it can be targeted directly through what&#039;s on the plate.</description>
                    <link>https://medicalxpress.com/news/2026-11-mediterranean-diet-fat-pancreas-blood.html</link>
                    <category></category>
                    <pubDate>Thu, 12 Nov 2026 15:20:01 EST</pubDate>
                    <guid isPermaLink="false">news713708911</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/mediterranean-meal.jpg" width="90" height="90" />
                                    </item>
                    </channel>
</rss>
